Cibc Bancorp Usa Inc. Travere Therapeutics, Inc. Transaction History
Cibc Bancorp Usa Inc.
- $80.8 Billion
- Q3 2025
A detailed history of Cibc Bancorp Usa Inc. transactions in Travere Therapeutics, Inc. stock. As of the latest transaction made, Cibc Bancorp Usa Inc. holds 9,398 shares of TVTX stock, worth $318,498. This represents 0.0% of its overall portfolio holdings.
Number of Shares
9,398Holding current value
$318,498% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding TVTX
# of Institutions
259Shares Held
104MCall Options Held
1.99MPut Options Held
809K-
Janus Henderson Group PLC London, X010.6MShares$359 Million0.12% of portfolio
-
Armistice Capital, LLC New York, NY8.88MShares$301 Million2.3% of portfolio
-
Black Rock Inc. New York, NY7.64MShares$259 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.61MShares$224 Million0.0% of portfolio
-
Macquarie Group LTD Australia, C34.98MShares$169 Million0.14% of portfolio
About Travere Therapeutics, Inc.
- Ticker TVTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 64,173,600
- Market Cap $2.17B
- Description
- Travere Therapeutics, Inc., a biopharmaceutical company, focuses on the identification, development, commercialization, and delivering of therapies for the treatment of rare diseases. Its marketed products include Chenodal, a synthetic oral form of chenodeoxycholic acid for the treatment of radiolucent stones in gallbladders; Cholbam, a cholic a...